Login
Register
Submit a Paper
Propose a Special lssue
Open Access
EDITORIAL COMMENT
Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer
Centre for Applied Urological Research
Queen’s University
Kingston, Ontario, Canada
Canadian Journal of Urology 2008, 15(5), 4256-4256.
Download PDFAbstract
This article has no abstract.Cite This Article
APA Style
Morales, A. (2008). Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer. Canadian Journal of Urology, 15(5), 4256–4256.
Vancouver Style
Morales A. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer. Can J Urology. 2008;15(5):4256–4256.
IEEE Style
A. Morales, “Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer,” Can. J. Urology, vol. 15, no. 5, pp. 4256–4256, 2008.
Copyright © 2008 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
